Psychological mindedness and cognitive styleBEITEL, Mark; FERRER, Elena; CECERO, John J et al.Journal of clinical psychology. 2004, Vol 60, Num 6, pp 567-582, issn 0021-9762, 16 p.Article

Psychological mindedness and awareness of self and othersBEITEL, Mark; FERRER, Elena; CECERO, John J et al.Journal of clinical psychology. 2005, Vol 61, Num 6, pp 739-750, issn 0021-9762, 12 p.Article

A comparison of the effects of nevirapine and nelfinavir on metabolism and body habitus in antiretroviral-naive human immunodeficiency virus-infected patients: A randomized controlled studyFISAC, Cesar; VIRGILI, Nuria; FERRER, Elena et al.The Journal of clinical endocrinology and metabolism. 2003, Vol 88, Num 11, pp 5186-5192, issn 0021-972X, 7 p.Article

Evaluation of the Safety and Effectiveness of Nevirapine Plus Coformulated Tenofovir/Emtricitabine as First-Line Therapy in Routine Clinical PracticeVALLECILLO, Gabriel; DOMINGO, Pere; MALLOLAS, Josep et al.AIDS research and human retroviruses. 2012, Vol 28, Num 2, pp 165-170, issn 0889-2229, 6 p.Article

How Much Fat Loss Is Needed for Lipoatrophy to Become Clinically Evident?PODZAMCZER, Daniel; FERRER, Elena; MARTINEZ, Esteban et al.AIDS research and human retroviruses. 2009, Vol 25, Num 6, pp 563-567, issn 0889-2229, 5 p.Article

Early virological failure with a combination of tenofovir, didanosine and efavirenzPODZAMCZER, Daniel; FERRER, Elena; GATELL, Josep Maria et al.Antiviral therapy (London). 2005, Vol 10, Num 1, pp 171-177, issn 1359-6535, 7 p.Article

Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapinePLANA, Montserrat; FERRER, Elena; MIRO, José M et al.Antiviral therapy (London). 2004, Vol 9, Num 2, pp 197-204, issn 1359-6535, 8 p.Article

Efficacy and Safety of Switching From Boosted Lopinavirto Boosted Atazanavir in Patients With Virological Suppression Receiving a LPV/r-Containing HAART: The ATAZI P StudyMALLOLAS, Josep; PODZAMCZER, Daniel; ALBERTO ARRANZ, José et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 51, Num 1, pp 29-36, issn 1525-4135, 8 p.Article

Epidemiology of Human Papillomavirus Infection in Men, Cancers other than Cervical and Benign ConditionsGIULIANO, Anna R; TORTOLERO-LUNA, Guillermo; FERRER, Elena et al.Vaccine. Supplement. 2008, Vol 26, Num 10, issn 1359-5938, K17-K28Article

Cervical Cancer Screening Programs in Latin America and the CaribbeanMURILLO, Raul; ALMONTE, Maribel; PEREIRA, Ana et al.Vaccine. Supplement. 2008, Vol 26, Num 11, issn 1359-5938, L37-L48Article

Short-term transdermal estradiol enhances nitric oxide synthase III and estrogen receptor mRNA expression in arteries of women with coronary artery diseaseSITGES, Marta; LEIVAS, Alberto; HERAS, Magda et al.International journal of cardiology. 2005, Vol 105, Num 1, pp 74-79, issn 0167-5273, 6 p.Article

Short Communication: High Effectiveness of Etravirine in Routine Clinical Practice in Treatment-Experienced HIV Type 1-Infected PatientsSANTOS, José R; LLIBRE, Josep M; DOMINGO, Pere et al.AIDS research and human retroviruses. 2011, Vol 27, Num 7, pp 713-717, issn 0889-2229, 5 p.Article

Less lipoatrophy and better lipid profile with abacavir as compared to stavudine : 96-week results of a randomized studyPODZAMCZER, Daniel; FERRER, Elena; LLIBRE, Josep M et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 44, Num 2, pp 139-147, issn 1525-4135, 9 p.Article

Nevirapine-containing regimens in HIV-infected naive patients with CD4 cell counts of 200 cells/μl or lessFERRER, Elena; SANTAMARINA, Elena; DOMINGO, Pere et al.AIDS (London). 2004, Vol 18, Num 12, pp 1727-1729, issn 0269-9370, 3 p.Article

A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the combine study)PODZAMCZER, Daniel; FERRER, Elena; OCANA, Imma et al.Antiviral therapy (London). 2002, Vol 7, Num 2, pp 81-90, issn 1359-6535Article

Impact of Switching from Lopinavir/Ritonavir to Atazanavir/Ritonavir on Body Fat Redistribution in Virologically Suppressed HIV-Infected AdultsFERRER, Elena; DEL RIO, Luis; GATELL, Josep M et al.AIDS research and human retroviruses. 2011, Vol 27, Num 10, pp 1061-1065, issn 0889-2229, 5 p.Article

Restoration of T Cell Responses to Toxoplasma gondii after Successful Combined Antiretroviral Therapy in Patients with AIDS with Previous Toxoplasmic EncephalitisLEJEUNE, Marylène; MIRO, José M; FERRER, Elena et al.Clinical infectious diseases. 2011, Vol 52, Num 5, pp 662-670, issn 1058-4838, 9 p.Article

Immune Reconstitution in Severely Immunosuppressed Antiretroviral-Naive HIV Type 1-Infected Patients Using a Nonnucleoside Reverse Transcriptase Inhibitor-Based or a Boosted Protease Inhibitor-Based Antiretroviral Regimen: Three-Year Results (The Advanz Trial): A Randomized, Controlled TrialMIRO, José M; MANZARDO, Christian; DE LAZZARI, Elisa et al.AIDS research and human retroviruses. 2010, Vol 26, Num 7, pp 747-757, issn 0889-2229, 11 p.Article

Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy : PISCIS Cohort (Spain)JAEN, Angeles; ESTEVE, Anna; VILARO, Josep et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 2, pp 212-220, issn 1525-4135, 9 p.Article

Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapineFISAC, Cesar; FUMERO, Emilio; CRESPO, Manuel et al.AIDS (London). 2005, Vol 19, Num 9, pp 917-925, issn 0269-9370, 9 p.Article

Detection of latent tuberculosis by the tuberculin skin test and a whole-blood interferon-γ release assay, and the development of active tuberculosis in HIV-seropositive personsSANTIN, Miguel; CASAS, Susana; SAUMOY, Maria et al.Diagnostic microbiology and infectious disease. 2011, Vol 69, Num 1, pp 59-65, issn 0732-8893, 7 p.Article

Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological FindingsBRUNI, Laia; DIAZ, Mireia; CASTELLSAGUE, Xavier et al.The Journal of infectious diseases. 2010, Vol 202, Num 12, pp 1789-1799, issn 0022-1899, 11 p.Article

A Simplification Trial Swritching From Nucleoside Reverse Transcriptase Inhibitors to Once-Daily Fixed-Dose Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1-Infected Patients With Virological SuppressionMARTINEZ, Esteban; ARRANZ, José A; BLANCO, José L et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 51, Num 3, pp 290-297, issn 1525-4135, 8 p.Article

Zidovudine/Lamivudine/Abacavir Plus Tenofovir in HIV-lnfected Naive Patients : A 96-Week Prospective One-Arm Pilot StudyFERRER, Elena; GATELL, Jose Maria; GUTIERREZ, Mar et al.AIDS research and human retroviruses. 2008, Vol 24, Num 7, pp 931-934, issn 0889-2229, 4 p.Article

Genotype and phenotype at baseline and at failure in human immunodeficiency virus-infected antiretroviral-naive patients in a randomized trial comparing zidovudine and lamivudine plus nelfinavir or nevirapineFERRER, Elena; PODZAMCZER, Daniel; GUDIOL, Francisco et al.The Journal of infectious diseases. 2003, Vol 187, Num 4, pp 687-690, issn 0022-1899, 4 p.Article